Neuromodulation trials

Neuromodulation and Cognitive Training for Substance Use Disorders

RecruitingNCT04426214Phase: NAStarted 2021-07-16

Summary

The relapsing nature of substance use disorder is a major obstacle to successful treatment. About 70% of those entering treatment will relapse within one year. To improve treatment outcome, new interv

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
65 Years

Locations

University of Minnesota FairviewMinneapolis, Minnesota, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT04426214